SEC Filings
Macro Bank Repurchases 45,298 Class B Shares For Ps$ 445,750,985
The Argentine lender paid an average Ps$ 9,840.412 a share, according to a notice to the country's securities regulator.
SEC Filings
The Argentine lender paid an average Ps$ 9,840.412 a share, according to a notice to the country's securities regulator.
SEC Filings
A convertible note sale, a term loan payoff and heavy repurchases left Tenable with a $26.5 million stockholders' deficit.
SEC Filings
A $668.3 million quarterly loss hit the eye-drug maker's balance sheet, and its cash runway assumes no milestone payments come due.
SEC Filings
Rhythm Pharmaceuticals will pay to cut a bivamelagon royalty to 1%, while two later loan tranches depend on conditions or lender consent.
SEC Filings
Nurix remains eligible for payments on other licensed programs in its Sanofi collaboration, which Sanofi may develop at its discretion.
SEC Filings
The contract logistics company reaffirmed 2026 guidance, reported a record $3.1 billion sales pipeline and set Investor Day for November 16.
SEC Filings
The bigger revolver runs to October 2031, but lenders' commitments lapse if conditions are unmet by May 9, 2027.
SEC Filings
Three Class II directors won three-year terms, and Scott Ostfeld drew 6,702,156 withheld votes, the most of the three.
SEC Filings
The biotech will not advance SPY072 in rheumatic disease and is pointing an October offering at a pivotal hidradenitis suppurativa program.
SEC Filings
The drugmaker held its 2026 revenue and spending forecasts and finished enrolling its constipation trial ahead of schedule.
SEC Filings
The insurer's board is still searching for a permanent CEO after moving the retirement up from December 31 for personal reasons.
SEC Filings
The company's own research puts peak sales potential at $1.5 - 2.0 billion, and it says €153.3 million in cash lasts through 2029.